SCRC...News Out! >.....December 18, 2013 - 8:30 AM EST
SCRC 0.111 -0.019
ScripsAmerica's Pharmaceutical Joint Venture Generates Over $116,000 in Revenue for November
Company's Joint Venture Records Excellent Gross Sales Despite Thanksgiving Holiday
TYSONS CORNER, Va., Dec. 18, 2013 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has received and processed $116,987 in orders during November from its recent pharmaceutical distribution joint venture ("JV").
The JV has generated $246,781 in revenue for October and November as a result of ScripsAmerica providing independent pharmacies with wholesale prescription drugs. October and November's combined sales of over $245,000 keep ScripsAmerica on a run rate of over $1.4 million solely for this joint venture.
"November proved to be a very strong month in sales for our joint venture even with the Thanksgiving holiday, therefore keeping pace with previous months. Our run rate continues to be in the $1.5 million range and we expect to increase this rate as our partner continues its growth in the industry. We fully expect that wholesale pharmaceutical distribution to independent pharmacies will remain an area of steady growth for ScripsAmerica and our shareholder value throughout 2014," stated CEO of ScripsAmerica, Bob Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
